CARDIOGEN SCIENCES
CardioGen Sciences is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. It was founded in 2014 and is based in Palo Alto, California.
CARDIOGEN SCIENCES
Industry:
Biotechnology Genetics Medical
Founded:
2014-01-01
Address:
Palo Alto, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
526 K USD
Similar Organizations
Current Advisors List
Board_member
Founder
Investors List
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Seed Round - CardioGen Sciences
More informations about "CardioGen Sciences"
CardioGen Sciences Company Profile 2025: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for CardioGen Sciences. Use the PitchBook Platform to explore the full profile.See details»
CardioGen Sciences - Funding, Financials, Valuation & Investors
In funding over 1 round. This was a Seed round raised on Nov 6, 2014. CardioGen Sciences is funded by Asset Management Ventures (AMV).See details»
Cardiogen Sciences - Ownership and Business Overview - Mergr
Sep 1, 2015 Cardiogen Sciences, Inc. is a biotechnology company focused on the discovery and development of adeno-associated virus (AAV) gene therapy products for rare, inherited …See details»
Cardiogen Sciences - Products, Competitors, Financials, Employees ...
Sep 1, 2015 Cardiogen Sciences is developing gene therapy solutions for orphan inherited arrhythmogenic diseases. Use the CB Insights Platform to explore Cardiogen Sciences's full …See details»
CardioGen Sciences acquired by Audentes Therapeutics
Acquiring Organization: Audentes Therapeutics Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.See details»
Cardiogen Sciences, Inc. in Palo Alto, California - EIN TaxId
Cardiogen Sciences, Inc. is a corporation in Palo Alto, California. The employer identification number (EIN) for Cardiogen Sciences, Inc. is 465566374. EIN for organizations is sometimes …See details»
Cardiogen Sciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Cardiogen Sciences, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
CARDIOGEN SCIENCES, INC. - HIPAASpace
CARDIOGEN SCIENCES, INC. Conformed submission company name, business name, organization name, etc.See details»
Audentes Therapeutics Acquires Cardiac Gene Therapy Company …
Sep 1, 2015 Audentes Therapeutics Acquires Cardiac Gene Therapy Company Cardiogen Sciences Audentes Expands Portfolio to Include AAV Gene Therapy for Rare, Genetic Cardiac …See details»
Audentes Therapeutics Acquires Cardiac Gene Therapy Company …
Sep 1, 2015 Audentes Therapeutics announces the acquisition of cardiac gene therapy company Cardiogen Sciences whose lead AAV program targets inherited cardiac arSee details»
Audentes Therapeutics Acquires Cardiogen Sciences
Sep 1, 2015 The deal will expand Audentes’ portfolio by adding to it a third preclinical program—Cardiogen’s lead program for the CASQ2 subtype of catecholaminergic …See details»
Cardiogen: Everything You Need to Know About This Bioregulator …
Aug 25, 2023 Topics quick find: IntroductionWhat is Cardiogen?Cardiogen and Cardiac SystemCardiogen and Prostate CancerCardiogen and Tumour GrowthConclusionSources: …See details»
CardioGen Sciences - Crunchbase
Developing gene therapy solutions for orphan inherited arrhythmogenic diseasesSee details»
Sage Business Cases - Advancing the CardioGen Pipeline
Jan 3, 2022 As a result, Life Sciences companies have governance committees to evaluate proposals to advance pipeline assets. For CardioGen, the fictional company that is the subject …See details»
Cardiogen Peptide: Studies on cardiac tissues & cancerous cells
Oct 14, 2024 Cardiogen is a short peptide classified as a bioregulator, primarily recognized for its potential influence on fibroblasts-cells responsible for tissue repair and scar formation.See details»
Cardiogen: The Heart-Boosting Bioregulator Peptide for Optimal …
In the pursuit of improving cardiovascular health, modern science is increasingly turning to bioregulator peptides as a means to support heart function and prevent age-related decline. …See details»
CardioGen Sciences - Updates, News, Events, Signals & Triggers
Developing gene therapy solutions for orphan inherited arrhythmogenic diseasesSee details»
Cardiogenic shock and extracorporeal membrane oxygenation: …
Mar 17, 2025 Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used to provide cardiorespiratory support in cardiogenic shock, but selection of patients and timing of ECMO …See details»
75 Years of WMO Science for Action
19 hours ago The World Meteorological Organization celebrates 75 years as a specialized agency of the United Nations in 2025, turning science into action for the global good. The …See details»
CardioGen Sciences - Contacts, Employees, Board Members
We're working on getting contact data for CardioGen SciencesSee details»